Anika Therapeutics Ownership | Who Owns Anika Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Anika Therapeutics Ownership Summary

Anika Therapeutics is owned by 85.93% institutional investors, 5.97% insiders, and 8.10% retail investors. Blackrock is the largest institutional shareholder, holding 10.93% of ANIK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Anika Therapeutics shares.

ANIK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anika Therapeutics	85.93%	5.97%	8.10%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Medical Device Stocks	36.89%	11.20%	51.91%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	1.61M	10.93%	$40.70M
Blackrock funding, inc. /de	1.45M	10.71%	$21.21M
Caligan partners lp	1.44M	10.01%	$20.81M
Morgan stanley	872.07K	6.08%	$12.64M
Vanguard group	779.16K	5.43%	$7.49M
Acadian asset management	606.54K	4.23%	$8.79M
Boothbay fund management	529.50K	3.69%	$7.68M
Renaissance	502.22K	3.50%	$7.28M
Capital management corp /va	448.47K	3.31%	$6.56M
Dimensional fund advisors lp	458.85K	3.20%	$6.65M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Caligan partners lp	1.44M	1.38%	$20.81M
Cove street capital	101.96K	1.25%	$958.39K
Capital management corp /va	448.47K	0.98%	$6.56M
Diker management	53.66K	0.69%	$778.10K
Ironwood investment management	65.57K	0.40%	$950.72K
R squared	27.07K	0.21%	$395.96K
Globeflex capital l p	87.60K	0.19%	$1.27M
Virtus fund advisers	2.72K	0.14%	$44.84K
Palumbo wealth management	39.43K	0.14%	$571.68K
Boothbay fund management	529.50K	0.10%	$7.68M

Top Buyers

Holder	Shares	% Assets	Change
Aqr capital management	272.27K	0.00%	202.99K
Ubs group	133.07K	0.00%	104.53K
Morgan stanley	872.07K	0.00%	99.84K
Jefferies financial group	93.50K	0.01%	93.50K
Vanguard fiduciary trust	90.37K	0.00%	90.37K

Top Sellers

Holder	Shares	% Assets	Change
Opaleye management	-	-	-588.80K
Alta fundamental advisers	-	-	-454.94K
Stonepine capital management	-	-	-190.59K
Meros investment management, lp	-	-	-173.49K
Trigran investments	-	-	-168.40K

New Positions

Holder	Shares	% Assets	Change	Value
Jefferies financial group	93.50K	0.01%	93.50K	$1.36M
Vanguard fiduciary trust	90.37K	0.00%	90.37K	$1.31M
Palumbo wealth management	39.43K	0.14%	39.43K	$571.68K
Cubist systematic strategies	37.45K	0.00%	37.45K	$352.00K
Hillsdale investment management	25.40K	0.01%	25.40K	$368.30K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-3.00
Assetmark	-3.00
Hexagon capital partners	-8.00
Ronald blue trust	-24.00
Cornerstone planning group	-27.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	127	1.60%	12,322,126	0.80%	85	1.19%	70	-6.67%	40	17.65%
Dec 31, 2025	24	-78.95%	1,655,041	-86.47%	11	0.16%	11	-84.06%	9	-65.38%
Sep 30, 2025	39	-61.39%	1,942,121	-84.69%	13	0.17%	25	-54.55%	8	-74.19%
Jun 30, 2025	101	-6.48%	12,685,036	3.92%	88	1.21%	54	12.50%	31	-24.39%
Mar 31, 2025	109	-1.80%	12,677,819	1.18%	88	1.23%	48	-11.11%	42	7.69%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	439.41K	3.10%	-
Vanguard Morn Total Stk Mkt Idx Investor	397.82K	2.99%	-30.80K
Vanguard Total Stock Mkt Idx Inv	397.82K	2.99%	-30.80K
iShares Russell 2000 ETF	304.57K	2.28%	-5.38K
CMC SMID	235.56K	1.77%	-3.43K
CMC All-Cap Growth	178.43K	1.34%	5.58K
CREF Total Global Stock Account R3	166.09K	1.25%	41.05K
Vanguard Institutional Extnd Mkt Idx Tr	162.46K	1.22%	-
Fidelity Small Cap Index	122.72K	0.92%	1.15K
BlackRock Credit Strategies Instl	132.11K	0.92%	75.46K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 04, 2026	Fischetti Gary P	-	Buy	$20.32K
Aug 03, 2026	Fischetti Gary P	-	Buy	$20.75K
May 01, 2026	HENNEMAN JOHN B III	-	Buy	$73.32K
Apr 30, 2026	Griffin Stephen D.	President and CEO	Buy	$149.88K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	2	-
2026 Q2	2	-
2026 Q1	-	-
2025 Q2	-	-
2025 Q1	-	-

ANIK Ownership FAQ

Who Owns Anika Therapeutics?

Anika Therapeutics shareholders are primarily institutional investors at 85.93%, followed by 5.97% insiders and 8.10% retail investors. The average institutional ownership in Anika Therapeutics's industry, Medical Device Stocks, is 36.89%, which Anika Therapeutics exceeds.

Who owns the most shares of Anika Therapeutics?

Anika Therapeutics’s largest shareholders are Blackrock (1.61M shares, 10.93%), Blackrock funding, inc. /de (1.45M shares, 10.71%), and Caligan partners lp (1.44M shares, 10.01%). Together, they hold 31.66% of Anika Therapeutics’s total shares outstanding.

Does Blackrock own Anika Therapeutics?

Yes, BlackRock owns 10.93% of Anika Therapeutics, totaling 1.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 40.7M$. In the last quarter, BlackRock increased its holdings by 45.79K shares, a 2.93% change.

Who is Anika Therapeutics’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Anika Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.38% of its assets in 1.44M Anika Therapeutics shares, valued at 20.81M$.

Who is the top mutual fund holder of Anika Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anika Therapeutics shares, with 3.10% of its total shares outstanding invested in 439.41K Anika Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools